Japan Entry Acceleration Program (JEAP) 2026 – Regenerative Medicine
infoAbout this program
JETRO program for overseas regenerative-medicine, cell/gene therapy, tissue-engineering and ATMP companies exploring Japan entry; program period is November 2026–February 2027 and about 10 companies are expected.
inventory_2What's Included
5 itemsInvestment
Tailored mentoring, Japan market/regulatory insight, introductions to CDMOs/CROs and a Japan Demo Day; no cash amount stated
Equity
See program
Duration
Varies
Program
Japan Entry Acceleration Program (JEAP) 2026 – Regenerative Medicine
Type
Accelerator
checklistEligibility
4 items- check_circleEarly Stage
- check_circleFocus: Startups
- check_circleLocation: Japan
- check_circleRegion: Japan
directions_runHow to Apply
4 steps- 1
Review Japan Entry Acceleration Program (JEAP) 2026 – Regenerative Medicine eligibility (Early Stage; focus: Startups).
- 2
Prepare pitch deck, team bios, and traction metrics.
- 3
Submit via https://www.jetro.go.jp/form5/pub/ive/jeap26_rm.
- 4
Complete interviews if invited; accept offer and join the cohort.